InvestorsHub Logo
Followers 122
Posts 8884
Boards Moderated 0
Alias Born 10/05/2004

Re: vinmantoo post# 696

Friday, 03/23/2018 9:48:21 AM

Friday, March 23, 2018 9:48:21 AM

Post# of 796
it's frustrating but this actually reminds me so much of THERF. With that company (i still hold shares), they already had one drug approved. This second one they were trying to get approved had BTD, fast track and orphan. Pdufa was set for early January but many thought it would be approved in october/november. company came out with the same PR where they furnished new info to the FDA and the FDA issued a 3 month delay. the stock sold off but then quickly recovered as cooler heads prevailed. there was no issue with the data, just additional manufacturing info the FDA needed to review. The FDA issued their standard 3 month delay letter. This was not a CRL. Anyway, the FDA ended up approving about a month ago which was about 1-2 months earlier than the 3 month delay would have put them at. Same here with PGNX.

"Don't worry about the world coming to an end today. It's already tomorrow in Australia"